Inovio Pharmaceuticals Inc (INO)
12.10
+0.09
(+0.75%)
USD |
NASDAQ |
May 03, 16:00
12.12
+0.02
(+0.17%)
After-Hours: 20:00
Inovio Pharmaceuticals Cash from Financing (Quarterly): 1.838M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.838M |
| September 30, 2023 | 0.6986M |
| June 30, 2023 | 2.883M |
| March 31, 2023 | -0.4247M |
| December 31, 2022 | 6.668M |
| September 30, 2022 | 3.812M |
| June 30, 2022 | 42.94M |
| March 31, 2022 | 28.42M |
| December 31, 2021 | 47.59M |
| September 30, 2021 | -0.4408M |
| June 30, 2021 | 3.441M |
| March 31, 2021 | 160.90M |
| December 31, 2020 | 126.94M |
| September 30, 2020 | -1.695M |
| June 30, 2020 | 126.52M |
| March 31, 2020 | 213.51M |
| December 31, 2019 | 9.645M |
| September 30, 2019 | 15.58M |
| June 30, 2019 | 1.294M |
| March 31, 2019 | 78.88M |
| December 31, 2018 | 14.39M |
| September 30, 2018 | 14.56M |
| June 30, 2018 | 2.584M |
| March 31, 2018 | -0.5064M |
| December 31, 2017 | -0.1247M |
| Date | Value |
|---|---|
| September 30, 2017 | 70.89M |
| June 30, 2017 | 24.10M |
| March 31, 2017 | 0.8264M |
| December 31, 2016 | 0.8703M |
| September 30, 2016 | 4.369M |
| June 30, 2016 | 2.478M |
| March 31, 2016 | 0.0695M |
| December 31, 2015 | 0.1594M |
| September 30, 2015 | 1.727M |
| June 30, 2015 | 82.46M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 1.167M |
| September 30, 2014 | 0.4987M |
| June 30, 2014 | 0.9051M |
| March 31, 2014 | 69.89M |
| December 31, 2013 | 4.522M |
| September 30, 2013 | 28.60M |
| June 30, 2013 | 0.0059M |
| March 31, 2013 | 19.56M |
| December 31, 2012 | 4.100M |
| September 30, 2012 | 1.226M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 3.688M |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.695M
Minimum
Sep 2020
213.51M
Maximum
Mar 2020
41.59M
Average
6.668M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| Cerus Corp | 1.183M |
| Stereotaxis Inc | 0.026M |
| Viemed Healthcare Inc | -3.03M |
| AIM ImmunoTech Inc | 0.147M |
| Protalix BioTherapeutics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -26.28M |
| Cash from Investing (Quarterly) | 19.94M |
| Free Cash Flow | -124.69M |
| Free Cash Flow Per Share (Quarterly) | -1.156 |
| Free Cash Flow to Equity (Quarterly) | -26.56M |
| Free Cash Flow Yield | -46.48% |